Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 18;18(13):4884–4900. doi: 10.7150/ijbs.74647

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Accumulation of CCL5⁺ TAMs distinguished clinical outcomes in patients with ccRCC. (A) The necessary transcription signatures composing CCL5⁺ TAMs were enrolled in Lasso regression analysis to establish the CCL5⁺ TAMs model for 530 patients with ccRCC from validation TCGA cohort. (B-C) Kaplan-Meier and log-rank tests identify prognostic value of TAMs infiltration alone in validation set (n=530) from TCGA cohort. (D-E) Kaplan-Meier and log-rank tests identify prognostic value of CCL5⁺ TAMs infiltration in validation set (n=530) from TCGA cohort.